锦波生物
(920982)
| 流通市值：84.68亿 | | | 总市值：181.18亿 |
| 流通股本：5546.51万 | | | 总股本：1.19亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,065,042,665.24 | 771,082,522.84 | 375,372,555.96 | 1,595,372,919.28 |
| 营业收入 | 1,065,042,665.24 | 771,082,522.84 | 375,372,555.96 | 1,595,372,919.28 |
| 二、营业总成本 | 675,740,310.75 | 445,677,659.51 | 218,368,822.25 | 825,957,509.81 |
| 营业成本 | 173,479,561.23 | 117,961,559.46 | 56,981,893.11 | 172,119,657.78 |
| 税金及附加 | 18,937,413.7 | 13,238,907.16 | 6,655,245.34 | 27,271,605.1 |
| 销售费用 | 277,925,924.24 | 181,723,004.53 | 87,892,692.94 | 375,946,448.97 |
| 管理费用 | 115,893,274.8 | 83,007,323.11 | 41,347,360.26 | 136,520,971.34 |
| 研发费用 | 79,559,600.45 | 42,855,905 | 22,470,678.12 | 106,011,667.35 |
| 财务费用 | 9,944,536.33 | 6,890,960.25 | 3,020,952.48 | 8,087,159.27 |
| 其中:利息费用 | 8,623,806.29 | 5,625,837.32 | 2,428,335.95 | 7,375,624.82 |
| 其中:利息收入 | 471,995.23 | 342,293.02 | 203,061.63 | 855,599.4 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 7,856,894.03 | 4,822,721.42 | 2,052,393.98 | 6,176,174.86 |
| 资产减值损失(新) | -1,902,567.88 | -1,216,013.93 | -364,911.98 | -23,085,134.39 |
| 信用减值损失(新) | -8,330,234.68 | -5,235,420.49 | -1,158,924.4 | -8,027,981.08 |
| 其他收益 | 34,269,590.15 | 12,199,300.66 | 9,534,547.26 | 23,808,685.36 |
| 四、营业利润 | 421,196,036.11 | 335,975,450.99 | 167,066,838.57 | 768,287,154.22 |
| 加:营业外收入 | 324,866.37 | 241,208.37 | 36,551.13 | 639,821.45 |
| 减:营业外支出 | 4,365,037.2 | 806,687.04 | 138,703.18 | 8,566,680.85 |
| 五、利润总额 | 417,155,865.28 | 335,409,972.32 | 166,964,686.52 | 760,360,294.82 |
| 减:所得税费用 | 64,773,858.73 | 53,250,637.54 | 26,005,600.83 | 114,649,788.24 |
| 六、净利润 | 352,382,006.55 | 282,159,334.78 | 140,959,085.69 | 645,710,506.58 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 352,382,006.55 | 282,159,334.78 | 140,959,085.69 | 645,710,506.58 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 353,910,207.72 | 281,484,712.49 | 140,454,965.87 | 652,128,968.1 |
| 少数股东损益 | -1,528,201.17 | 674,622.29 | 504,119.82 | -6,418,461.52 |
| 扣除非经常损益后的净利润 | 322,347,450.27 | 268,049,768.55 | 131,092,491.15 | 635,506,016.42 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 3.08 | 2.45 | 1.22 | 5.67 |
| (二)稀释每股收益 | 3.08 | 2.45 | 1.22 | 5.67 |
| 九、综合收益总额 | 352,382,006.55 | 282,159,334.78 | 140,959,085.69 | 645,710,506.58 |
| 归属于母公司股东的综合收益总额 | 353,910,207.72 | 281,484,712.49 | 140,454,965.87 | 652,128,968.1 |
| 归属于少数股东的综合收益总额 | -1,528,201.17 | 674,622.29 | 504,119.82 | -6,418,461.52 |
| 公告日期 | 2026-10-28 | 2026-08-25 | 2026-04-29 | 2026-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |